Chair Succession Planning Update

Summary by AI ^BETAClose X

Rentokil Initial plc announced that its Chair, Richard Solomons, intends to retire once a successor is appointed, having served in the role since 2019. The search for a new Chair is underway, led by the Senior Independent Director and supported by the Nomination Committee, with a commitment to a smooth transition. Richard Solomons will continue to lead the Board until his replacement assumes responsibilities.

Disclaimer*

Rentokil Initial PLC

05 March 2026

5 March 2026

Chair Succession Planning Update

Rentokil Initial plc (LSE: RTO, NYSE: RTO) ("the Company") today announces that Richard Solomons, Chair of the Board, has informed the Board of his intention to retire, once a successor has been appointed.

The search for a new Chair is underway and, in accordance with the UK Corporate Governance Code, is being led by the Senior Independent Director, John Pettigrew, supported by the Nomination Committee. The Board is committed to ensuring a smooth transition, and Richard will continue to lead the Board until his successor has been appointed and assumed Chair responsibilities.

The Board thanks Richard for his strong leadership and significant contributions to the Company and looks forward to continuing to work with him until his successor is in place. Richard has served as the Chair of Rentokil Initial plc since 2019.

The Company will make a further announcement once the appointment of a new Chair has been finalised.

ENDS

For further information, please contact:

Investors / Analysts: Heather Wood, Rentokil Initial plc, +44 7808 098793

Media: Malcolm Padley, Rentokil Initial plc, +44 7788 978199

About Rentokil Initial plc:

Rentokil Initial plc is a global leader in Pest Control and Hygiene & Wellbeing services. It employs c.63,400 people in 90 countries.

www.rentokil-initial.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END